Squarepoint’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Buy |
+37,257
| New | +$349K | ﹤0.01% | 2090 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3186 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3005 |
|
|
2024
Q1 | – | Sell |
-52,035
| Closed | -$1.12M | – | 2896 |
|
|
2023
Q4 | $1.12M | Buy |
52,035
+22,915
| +79% | +$495K | ﹤0.01% | 1302 |
|
|
2023
Q3 | $423K | Sell |
29,120
-10,163
| -26% | -$148K | ﹤0.01% | 1728 |
|
|
2023
Q2 | $822K | Buy |
+39,283
| New | +$822K | ﹤0.01% | 1371 |
|
|
2021
Q3 | – | Sell |
-32,575
| Closed | -$559K | – | 2706 |
|
|
2021
Q2 | $559K | Buy |
32,575
+5,936
| +22% | +$102K | ﹤0.01% | 1536 |
|
|
2021
Q1 | $596K | Sell |
26,639
-64,488
| -71% | -$1.44M | ﹤0.01% | 1410 |
|
|
2020
Q4 | $2.03M | Buy |
91,127
+25,643
| +39% | +$570K | 0.02% | 750 |
|
|
2020
Q3 | $967K | Buy |
65,484
+45,171
| +222% | +$667K | 0.01% | 966 |
|
|
2020
Q2 | $301K | Sell |
20,313
-12,043
| -37% | -$178K | ﹤0.01% | 1562 |
|
|
2020
Q1 | $355K | Buy |
+32,356
| New | +$355K | 0.01% | 1206 |
|
|
2019
Q1 | – | Sell |
-18,601
| Closed | -$83K | – | 2358 |
|
|
2018
Q4 | $83K | Buy |
18,601
+6,303
| +51% | +$28.1K | ﹤0.01% | 1800 |
|
|
2018
Q3 | $99K | Buy |
+12,298
| New | +$99K | ﹤0.01% | 1880 |
|
|
2018
Q1 | – | Sell |
-10,216
| Closed | -$89K | – | 2101 |
|
|
2017
Q4 | $89K | Buy |
+10,216
| New | +$89K | ﹤0.01% | 1963 |
|